EGFR and hepatocellular carcinoma: Xiong, L. et al. Have proved that HCV-E2 increased the expression of miR-490 in MC-derived exosomes and receptor HCC cells, thereby decreasing the activity of the EGFR/AKT/ERK1/2 pathway and inhibiting the migration of HCC cells.